NAMA Applauds Bayer CropScience Decision to Withhold Pesticide from Canadian Oat MarketMay 11, 2004
CONTACT: Jim Bair, NAMA Vice President
WASHINGTON, D.C. – May 11, 2004 – NAMA reacted with praise today for the decision by Bayer CropScience (Bayer) not to market the fungicide Stratego for oats in Canada until the compound is approved in the U.S. The fungicide was approved for use up to 45 days prior to harvest on wheat, oats and barley in Canada, but only on wheat in the U.S. Hence, any Canadian oats or oat products with residues of Stratego would have been considered adulterated by the U.S. Food and Drug Administration.
NAMA president Betsy Faga said “We’re very pleased that Bayer has done the right thing, and we congratulate them for it. U.S. oat millers and Canadian oat farmers rely on each other. We need their oats, and they need us since the U.S. milling industry buys more than 95 percent of their oat exports.”
NAMA staff and counsel have been holding discussions with Bayer executives since March. NAMA had asked Bayer to withhold Stratego from the Canadian market pending U.S. registration of the product for oats.
Faga continued, “Safety and wholesomeness are non-negotiable. While Stratego residues would likely have presented no risk, the perceptions of the industry’s customers are of the highest importance.”
NAMA has 46 member companies operating 170 wheat, corn, oat and rye mills in 38 states and 150 cities. The aggregate production capacity of NAMA’s membership is more than 160 million pounds of product daily, which is about 95% of the total U.S. capacity.